|
18
|
99
|
7ma1A |
Hiv-1 protease (i84v) in complex with grl-98065 |
|
18
|
99
|
7maiA |
Hiv-1 protease (i84v) in complex with pu5 (lr4-47) |
|
17
|
99
|
7makA |
Hiv-1 protease (i84v) in complex with pu7 (lr3-67) |
|
18
|
99
|
7m9mA |
Hiv-1 protease wt (nl4-3) in complex with lr3-55 |
|
17
|
99
|
7le1A |
Hiv-1 protease wt (nl4-3) in complex with umass2 |
|
18
|
99
|
8fuiA |
Hiv-1 wild type protease with grl-02519a, with n-(2,5-dimethylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine as p2-p3 group |
|
18
|
99
|
8fujA |
Hiv-1 wild type protease with grl-03419a, with n-(2,5-dimethylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine as p2-p3 group and 3,5-difluorophenylmethyl as the p1 group |
|
18
|
99
|
8esxA |
Hiv protease in complex with benzoxaborolone analog of darunavir |
|
18
|
99
|
8esyA |
D30n mutant hiv protease in complex with benzoxaborolone analog of darunavir |
|
18
|
99
|
8f0fA |
Hiv-1 wild type protease with grl-110-19a, a chloroacetamide derivative based on darunavir as p2' group |
|
163
|
477
|
8e5wA |
Crystal structure of dehydroalanine hip1 |
|
18
|
99
|
7maaA |
Hiv-1 protease (i84v) in complex with umass10 |
|
17
|
99
|
7masA |
Drug resistant hiv-1 protease (l10f, m46i, i50v, f53l, l63p, g73s) in complex with drv |
|
18
|
99
|
7ma8A |
Hiv-1 protease (i84v) in complex with umass8 |
|
18
|
99
|
7ma6A |
Hiv-1 protease (i84v) in complex with umass5 |
|
18
|
99
|
7ma4A |
Hiv-1 protease (i84v) in complex with umass3 |
|
18
|
99
|
7maqA |
Drug resistant hiv-1 protease (l10f, v32i, l33f, k45i, a71v, v82i, i84v) in complex with drv |
|
17
|
99
|
7marA |
Drug resistant hiv-1 protease (l10f, m46i, i47v, i50v, f53l, l63p, i72v, g73s, v82i, i85v) in complex with drv |
|
18
|
99
|
7ma7A |
Hiv-1 protease (i84v) in complex with umass7 |
|
18
|
99
|
7ma5A |
Hiv-1 protease (i84v) in complex with umass4 |
|
18
|
99
|
7ma3A |
Hiv-1 protease (i84v) in complex with umass2 |
|
18
|
99
|
7mapA |
Drug resistant hiv-1 protease (l10i, v32i, l33f, k45i, m46i, i50v, a71v, v82i, i84v) in complex with drv |
|
18
|
99
|
7ma9A |
Hiv-1 protease (i84v) in complex with umass9 |
|
18
|
99
|
7wcqA |
Crystal structure of hiv-1 protease in complex with lactam derivative 1 |
|
16
|
99
|
7wbsA |
Crystal structure of hiv-1 protease in complex with lactam derivative 2 |
|
15
|
99
|
7yf6A |
Crystal structure of hiv-1 protease in complex with macrocyclic peptide |
|
1
|
7
|
7yf6C |
Crystal structure of hiv-1 protease in complex with macrocyclic peptide |
|
22
|
99
|
8dchA |
Crystal structure of a highly resistant hiv-1 protease clinical isolate pr10x with grl-0519 (tris-tetrahydrofuran as p2 ligand) |
|
18
|
99
|
8dciA |
Crystal structure of a highly resistant hiv-1 protease clinical isolate pr10x (inhibitor-free) |
|
17
|
99
|
7m9tA |
Hiv-1 protease wt (nl4-3) in complex with nr02-73 |
|
18
|
99
|
7m9sA |
Hiv-1 protease wt (nl4-3) in complex with nr01-141 |
|
17
|
99
|
7m9uA |
Hiv-1 protease wt (nl4-3) in complex with nr02-79 |
|
17
|
99
|
7m9wA |
Hiv-1 protease (i84v) in complex with nr02-73 |
|
18
|
99
|
7m9xA |
Hiv-1 protease (i84v) in complex with nr02-79 |
|
17
|
99
|
7m9vA |
Hiv-1 protease (i84v) in complex with nr01-141 |
|
46
|
203
|
7dpqA |
Hiv-1 protease d30n mutant |
|
45
|
203
|
7dozA |
Hiv-1 protease d30n mutant in complex with nelfinavir |
|
17
|
99
|
7n6tA |
Crystal structure of inhibitor-free hiv-1 prs17 revertant mutant prs17 v48g |
|
19
|
99
|
7n6xA |
Crystal structure of hiv-1 protease multiple mutants prs17 bound to inhibitor amprenavir |
|
18
|
99
|
7n6vA |
Crystal structure of hiv-1 protease multiple mutants prs17 with revertant mutation v48g bound to inhibitor amprenavir |
|
19
|
99
|
7myyA |
Crystal structure of hiv-1 prs17 with grl-142 |
|
104
|
423
|
7dbmB |
Hiv-1 reverse transcriptase mutant q151m/y115f/f116y/m184v:dna:dgtp ternary complex |
|
163
|
552
|
7dbmA |
Hiv-1 reverse transcriptase mutant q151m/y115f/f116y/m184v:dna:dgtp ternary complex |
|
20
|
99
|
7mypA |
Crystal structure of hiv-1 prs17 with grl-44-10a |
|
18
|
99
|
6w6tA |
Wt hiv-1 protease in complex with phosphonated umass6 (pu6) |
|
18
|
99
|
6uwcA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-08613 |
|
20
|
99
|
6uwbA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-08513 |
|
18
|
99
|
6vodA |
Hiv-1 wild type protease with grl-052-16a, a tricyclic cyclohexane fused tetrahydrofuranofuran (chf-thf) derivative as the p2 ligand |
|
19
|
99
|
6voeA |
Hiv-1 wild type protease with grl-019-17a, a tricyclic cyclohexane fused tetrahydrofuranofuran (chf-thf) derivative as the p2 ligand and a aminobenzothiazole(abt)-based p2'-ligand |
|
19
|
99
|
6vceA |
Hiv-1 wild type protease with grl-026-18a, a crown-like tetrahydropyranotetrahydrofuran with a bridged methylene group as a p2 ligand |
